RE:RE:RE:Cohodes Short SummaryWhat you have to understand is that the UK is a relatively small market dominated by one or two generic names for each aliement. This paves the ground to price increases since the cost of entering this market by another generic name is not justified by the potential future returns. This is called smart business. Do you realize how long it will take the politicians to fine these companies and change the laws. In the US, a market of 300 plus million people, with all the noise from Hilary for a year now and nothing has been yet, the U.K. Market if 50 million will never make these adjustments, inspite of the petition of over 150k signatures which I'm sure lattice and Marc cohedes have been busy signing it thousands of times each. You need the understand the political power that pharma has and then you will realize that thyou s is merely nothing but noise.